Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BZAINYSE:ENPCNASDAQ:FHLTNASDAQ:RENE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBZAIBlaize$2.35-3.3%$2.46$1.70▼$19.25$238.96M0.03594,081 shs169,626 shsENPCExecutive Network Partnering$5.96-2.3%$5.29$8.46▼$10.24$250.40M-0.04245,839 shs590,733 shsFHLTFuture Health ESG$10.96$11.25$10.10▼$15.05$65.10MN/AN/AN/ARENECartesian Growth Co. II$11.75$11.83$11.26▼$11.95$254.05M-0.0194,484 shs1 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBZAIBlaize-3.57%-6.54%-14.13%-30.97%+242,999,900.00%ENPCExecutive Network Partnering+3.21%+6.09%+11.31%+10.11%-3.79%FHLTFuture Health ESG0.00%0.00%0.00%0.00%0.00%RENECartesian Growth Co. II0.00%0.00%+0.64%-0.42%+4.17%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBZAIBlaizeN/AN/AN/AN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/AN/AN/AN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBZAIBlaize 3.00Buy$5.83148.23% UpsideENPCExecutive Network Partnering 0.00N/AN/AN/AFHLTFuture Health ESG 0.00N/AN/AN/ARENECartesian Growth Co. II 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest FHLT, BZAI, RENE, and ENPC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.004/22/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$3.004/8/2025BZAIBlaizeCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$4.50(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBZAIBlaize$458K521.74N/AN/AN/A∞ENPCExecutive Network PartneringN/AN/A$0.02 per share268.01($0.20) per shareN/AFHLTFuture Health ESGN/AN/AN/AN/A($1.56) per shareN/ARENECartesian Growth Co. IIN/AN/A$0.40 per share29.45($0.64) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBZAIBlaizeN/AN/A0.00∞N/AN/AN/AN/AN/AENPCExecutive Network Partnering$1.47MN/A0.004.17N/AN/A-74.23%-2.27%N/AFHLTFuture Health ESG-$50KN/A0.00∞N/AN/AN/AN/AN/ARENECartesian Growth Co. II$11.44MN/A0.00∞N/AN/A-51.08%5.43%8/13/2025 (Estimated)Latest FHLT, BZAI, RENE, and ENPC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BZAIBlaizeN/A-$0.29N/A-$1.61N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBZAIBlaizeN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBZAIBlaizeN/AN/AN/AENPCExecutive Network PartneringN/A0.020.02FHLTFuture Health ESGN/AN/AN/ARENECartesian Growth Co. IIN/A0.090.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBZAIBlaize97.12%ENPCExecutive Network Partnering88.58%FHLTFuture Health ESG24.57%RENECartesian Growth Co. II58.96%Insider OwnershipCompanyInsider OwnershipBZAIBlaize68.50%ENPCExecutive Network Partnering0.17%FHLTFuture Health ESG57.20%RENECartesian Growth Co. II26.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBZAIBlaizeN/A101.68 million32.00 millionN/AENPCExecutive Network Partnering142.01 million41.94 millionNot OptionableFHLTFuture Health ESG2,0215.94 million2.54 millionNot OptionableRENECartesian Growth Co. II221.62 million15.87 millionNot OptionableFHLT, BZAI, RENE, and ENPC HeadlinesRecent News About These CompaniesPolar Asset Management Partners Inc. Sells 142,000 Shares of Cartesian Growth Co. II (NASDAQ:RENE)May 19, 2025 | marketbeat.comCartesian Growth Corp II extends business combination periodMarch 5, 2025 | investing.comCartesian Growth Corp II extends business combination deadlineFebruary 5, 2025 | msn.comPositive Buy Rating for Cartesian Therapeutics Amid Encouraging Developments in Descartes-08 TrialsJanuary 28, 2025 | markets.businessinsider.comCartesian Growth Corporation IIDecember 23, 2024 | investing.comBertrand P. Grabowski's Net WorthNovember 2, 2024 | benzinga.comRENE’s Unexpected Plunge: What’s Next?October 31, 2024 | bovnews.comHow to Take Advantage of moves in (RENE)August 22, 2024 | news.stocktradersdaily.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeApple Stock Could Rally After Tariffs Are Blocked By CourtBy Gabriel Osorio-Mazilli | May 30, 2025View Apple Stock Could Rally After Tariffs Are Blocked By CourtTaiwan Semiconductor: Time to Buy After Strong NVIDIA Results?By Gabriel Osorio-Mazilli | May 30, 2025View Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results?Intel's Price Spikes: Noise, or the First Notes of a Turnaround?By Jeffrey Neal Johnson | June 13, 2025View Intel's Price Spikes: Noise, or the First Notes of a Turnaround?Boeing Landed New Deals With China and the Saudis for More UpsideBy Gabriel Osorio-Mazilli | May 20, 2025View Boeing Landed New Deals With China and the Saudis for More UpsideFHLT, BZAI, RENE, and ENPC Company DescriptionsBlaize NASDAQ:BZAI$2.35 -0.08 (-3.29%) As of 04:00 PM EasternBlaize® has created a transformative new compute solution that unites silicon and software to optimize AI from the edge to the core. We’re partnering with customers to transform their products so they can deliver better experiences and better lives.Executive Network Partnering NYSE:ENPC$5.96 -0.14 (-2.30%) As of 06/12/2025Executive Network Partnering Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar partnering transaction with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.Future Health ESG NASDAQ:FHLTFuture Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.Cartesian Growth Co. II NASDAQ:RENE$11.75 0.00 (0.00%) As of 05/13/2025Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
